fbpx Skip to main content

Member's Profile

Armata Pharmaceuticals, Inc.

4503 Glencoe Avenue
Marina Del Rey,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2021
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Armata Pharmaceuticals, Inc.
Biotech Company

AmpliPhi Biosciences (formerly called Targeted Genetics) is amping up the fight against bacterial infections. The drug developer focuses on anti-bacterial (bacteriophage) therapeutics. It was after the 2011 acquisition of Biocontrol that AmpliPhi reorganized itself; going from being focused on developing DNA-based gene therapies to encourage (or sometimes inhibit) the production of proteins associated with disease to its current focus of treatments for antibiotic-resistant bacterial infections. The field for anti-infective treatments is receiving great attention these days with the spread of antibiotic-resistant infections such as the deadly methicillin-resistant

Staphylococcus aureus

aka MRSA.

Related News
No related news posted by this Member